UBS lowered the firm’s price target on Bright Horizons (BFAM) to $112 from $138 and keeps a Neutral rating on the shares. Bright Horizons’ Q3 results should be largely consistent with consensus, with Backup Care again the highlight with more mixed dynamics within Full Service, the analyst tells investors in a research note. The stock’s recent move lower is surprising, but with moderating enrollment growth and a persistent revenue headwind from center count, some conviction in a floor for enrollment growth as well as visibility to stronger center count growth are likely needed for shares to work, the firm adds.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BFAM:
